Trial Profile
Randomised, Double-blind, Placebo-controlled Study of Topical GW842470X Formulation in Adults With Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs GW 842470 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 03 Aug 2014 New source identified and integrated (European Clinical Trials Database; EudraCT2005-005430-12)
- 17 Jan 2007